<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.896744</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Blockage of Galectin-Receptor Interactions Attenuates Mouse Hepatic Pathology Induced by <italic>Toxoplasma gondii</italic> Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>He</surname><given-names>Jian</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hou</surname><given-names>Yongheng</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1777619"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lu</surname><given-names>Fangli</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/256465"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Clinical Laboratory, The Seventh Affiliated Hospital, Sun Yat-sen University</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Wenyue Xu, Army Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jun Huang, Guangzhou Medical University, China; Shuai Wang, Xinxiang Medical University, China; Xuemei Hu, Binzhou Medical University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Fangli Lu, <email xlink:href="mailto:489589715@qq.com">489589715@qq.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>07</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>896744</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>05</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 He, Hou and Lu</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>He, Hou and Lu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p><italic>Toxoplasma gondii</italic> (<italic>T. gondii</italic>), one of the most important Apicomplexan protozoa, causes toxoplasmosis in human throughout the world. Galectin (Gal)-9 triggers a series of immune events <italic>via</italic> binding to its receptors, including T cell immunoglobulin and mucin-containing molecule 3, CD137, CD44, and protein disulfide isomerase. To examine the regulatory role of galectin-receptor interactions in anti-toxoplasmic activities, C57BL/6 mice were infected with <italic>T. gondii</italic> RH strain and intraperitoneally injected with alpha (&#x3b1;)-lactose to block the interactions of galectins and their receptors. Heatmaps showed upregulated values for Gal-9 and CD137 in the livers of <italic>T. gondii</italic>-infected mice and <italic>T. gondii</italic>-infected mice treated with &#x3b1;-lactose. Compared with <italic>T. gondii</italic>-infected mice, <italic>T. gondii</italic>-infected mice treated with &#x3b1;-lactose showed significantly increased survival rate, decreased tissue parasite burden, attenuated liver histopathology, increased mRNA expression levels of CD137, IFN&#x3b3;, IL-4, and IL-10 in the liver, and increased Gal-9 mRNA expression level in the spleen. Correlation analysis showed that significant positive correlations existed between the mRNA expression levels of Gal-9 and CD137, Gal-9 and IFN&#x3b3;, as well as between CD137 and IFN&#x3b3; in the liver and spleen of <italic>T. gondii</italic>-infected mice; between CD137 and IFN&#x3b3; in the liver of <italic>T. gondii</italic>-infected mice treated with &#x3b1;-lactose. In addition, blockage of galectin-receptor interactions showed enhanced M2 macrophage polarization in the liver of <italic>T. gondii</italic>-infected mice. Our data indicate that Gal-9-CD137 interaction may play an important role in <italic>T. gondii</italic> proliferation and liver inflammation in mice during acute <italic>T. gondii</italic> infection, through regulating T cell and macrophage immune responses.</p>
</abstract>
<kwd-group>
<kwd><italic>T. gondii</italic>
</kwd>
<kwd>C57BL/6 mice</kwd>
<kwd>Gal-9</kwd>
<kwd>CD137</kwd>
<kwd>hepatic pathology</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="60"/>
<page-count count="14"/>
<word-count count="5996"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p><italic>Toxoplasma gondii</italic> (<italic>T. gondii</italic>), a common and significant obligate protozoan parasite, is widely prevalent in humans and other animals on all continents (<xref ref-type="bibr" rid="B1">1</xref>). <italic>T. gondii</italic> infection can cause both congenital toxoplasmosis and postnatally acquired disease in immunocompromised patients (<xref ref-type="bibr" rid="B2">2</xref>), and its recrudescence can cause life-threatening disease in immunocompromised patients and recurrent ocular lesions in immunocompetent individuals (<xref ref-type="bibr" rid="B3">3</xref>). Toxoplasmic encephalitis is the most common cause of brain mass lesions in human immunodeficiency virus-infected patients (<xref ref-type="bibr" rid="B4">4</xref>). In addition, it has been reported a case of toxoplasmic hepatitis presenting with hepatomegaly in an immunocompetent patient (<xref ref-type="bibr" rid="B5">5</xref>). A study has confirmed the positive connection between toxoplasmosis and chronic liver diseases (<xref ref-type="bibr" rid="B6">6</xref>). The immune response against <italic>T. gondii</italic> infection is essential for parasite control and host survival, but it can also cause inflammation, tissue damage, and even death (<xref ref-type="bibr" rid="B7">7</xref>). Previous study has found that immune regulation may play an important role in modulating acute inflammatory pathogenesis and parasite control in the liver of mice infected with <italic>T. gondii</italic> (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Galectins are a class of &#x3b2;-galactoside-binding lectins that can bind to proteins by either <italic>N</italic>-linked or <italic>O</italic>-linked glycosylation (<xref ref-type="bibr" rid="B9">9</xref>). They are encoded by <italic>Lgals</italic> genes and differentially expressed by various immune cells, as well as a wide range of other cell types (<xref ref-type="bibr" rid="B10">10</xref>). Among the galectins, galectin (Gal)-9 is known for its immunomodulatory role in various microbial infections. It mediates host-pathogen interactions and regulates cell signaling <italic>via</italic> binding to its receptors (<xref ref-type="bibr" rid="B11">11</xref>). Gal-9 plays a crucial role in regulating effector T cells, and can transduce apoptosis of T helper (Th) 1 and Th17 cells by interacting with T cell immunoglobulin and mucin-containing molecule 3 (Tim-3), a transmembrane protein also known as CD366 (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). In addition, Gal-9 can also bind to three other receptors, the co-stimulatory receptor CD137 (also known as 4-1BB and TNFRSF9) (<xref ref-type="bibr" rid="B14">14</xref>), CD44 (<xref ref-type="bibr" rid="B15">15</xref>), and protein disulfide isomerase (PDI) (<xref ref-type="bibr" rid="B16">16</xref>). CD137 is a co-stimulatory member of the tumor necrosis factor receptor (TNFR) superfamily distributed on T cell surface, to preferentially induce CD137 signaling, subsequent IFN&#x3b3; production and Th1 response (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B17">17</xref>). CD44 is a broadly distributed cell-adhesion molecule, which is important for leukocyte migration (<xref ref-type="bibr" rid="B18">18</xref>), as well as the stability and function of iTreg cells (<xref ref-type="bibr" rid="B15">15</xref>). PDI can specifically bind to Gal-9, and enhance T cell migration and viral entry (<xref ref-type="bibr" rid="B19">19</xref>). Our previous study has shown that the mRNA expression levels of Gal-9, Tim-3, and CD137 were increased in the cervical lymph nodes of both genetically <italic>T. gondii</italic>-susceptible C57BL/6 mice and <italic>T. gondii</italic>-resistant BALB/c mice, indicating that Gal-9 and its receptor interactions may play an important role in the immune regulation during acute ocular <italic>T. gondii</italic> infection (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>Although <italic>T. gondii</italic> normally tends more to affect neurotropic and ocular organs, this parasite may also induce serious pathological changes in the liver (<xref ref-type="bibr" rid="B6">6</xref>), including hepatomegaly (<xref ref-type="bibr" rid="B5">5</xref>), granuloma hepatitis (<xref ref-type="bibr" rid="B21">21</xref>), cholestatic jaundice (<xref ref-type="bibr" rid="B22">22</xref>), and cirrhosis (<xref ref-type="bibr" rid="B23">23</xref>). Nonetheless, the immunopathological mechanisms those lead to the hepatic pathology in toxoplasmosis remain largely unknown. As an important immune protein highly expressed in the liver, Gal-9 presents a wide variety of biological functions involved in the maintenance of hepatic immune homeostasis and inflammation (<xref ref-type="bibr" rid="B24">24</xref>). However, it is not clear yet what roles of Gal-9 and its receptors play in the hepatic immunopathology during acute <italic>T. gondii</italic> infection. Therefore, the present study was designed to elucidate this question using <italic>T. gondii</italic>-infected murine models injected with alpha (&#x3b1;)-lactose to block galectin-receptor interactions and assess the consequent changes. Here we identified a critical role of Gal-9-CD137 interaction in the survival rate, parasite burden, liver pathology, and cytokine expressions in <italic>T. gondii</italic>-infected mice. These findings may provide the basis of developing galectin-receptor-targeted strategy for control of immunopathology during acute <italic>T. gondii</italic> infection.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Ethics Statement</title>
<p>Eight-week-old male C57BL/6 mice were purchased from the Animal Center of Sun Yat-sen University (Guangzhou, China), maintained in specific-pathogen-free environment, and had free access to a commercial basal diet and tap water <italic>ad libtum</italic>. Animals were provided with humane care and healthful conditions. All individuals who are involved in animal experiments received instruction in experimental methods and in the care, maintenance, and handling of mice; and all efforts were made to minimize animal suffering. Animals were sacrificed using CO<sub>2</sub> asphyxiation and the appropriate organs were harvested. The protocol used in this study was approved by the Committee on the Ethics of Animal Experiments of Sun Yat-sen University [Permit Numbers: SCXK (Guangdong) 2016&#x2013;0029].</p>
</sec>
<sec id="s2_2">
<title><italic>T. gondii</italic> and Experimental Infection</title>
<p>Tachyzoites of <italic>T. gondii</italic> RH strain were propagated by serial passage in human foreskin fibroblast-1 (HFF-1) cell (BNCC100406, BeNa Culture Collection, Beijing, China) monolayer grown in Dulbecco&#x2019;s modified eagle&#x2019;s medium (11995065, Gibco, Thermo Fisher Scientific Inc., Rockford, USA) supplemented with 10% (V/V) fetal bovine serum (10099141, Gibco, Thermo Fisher Scientific Inc.). After lysis of <italic>T. gondii</italic>-infected cells, tachyzoites were harvested by centrifugation at 2 000 &#xd7; g for 5 min. The tachyzoites were enumerated using manual counting with a hemocytometer, and experimental <italic>T. gondii</italic>-infected mice were intraperitoneally (i.p.) injected with 1&#xd7;10<sup>2</sup> tachyzoites.</p>
</sec>
<sec id="s2_3">
<title>&#x3b1;-Lactose Treatment</title>
<p>Galectins was blockaded by &#x3b1;-lactose to limit binding to their receptors as described previously (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). A total of 42 C57BL/6 mice were divided into 4 groups: 11 mice were infected with <italic>T. gondii</italic> tachyzoites (<italic>Tg-</italic>infected mice); 11 mice were infected with <italic>T. gondii</italic> tachyzoites and injected i.p. with 27 mM of &#x3b1;-lactose (L8040-100, Sigma-Aldrich, St. Louis, MO, USA) solution in PBS (<italic>Tg+</italic>lact mice) twice daily starting from day 0 post infection (p.i.) until death of the mice; 10 mice were injected i.p. with &#x3b1;-lactose solution twice daily as &#x3b1;-lactose control (lact mice), while 10 mice were injected with equal volume of PBS twice daily as uninfected control (uninfected mice). Mortality was monitored daily. Another 16 mice were equally divided into four groups. They were sacrificed by CO<sub>2</sub> asphyxiation on day 7 p.i., and the liver and spleen of each mouse were harvested for further analysis.</p>
</sec>
<sec id="s2_4">
<title>Antibodies</title>
<p>Antibodies used for <italic>in vitro</italic> analysis include anti-CD86 mAb (GB13585) and anti-CD206 pAb (GB113497) (Wuhan Servicebio Biotechnologies Co., Ltd., Wuhan, China), anti-&#x3b2;-actin mAb (BM0627) (Wuhan Boster Biological Engineering Co., Ltd., Wuhan, China), anti-&#x3b2;-tubulin mAb (3G6) (Abbkine Inc., Wuhan, China), anti-38 kDa protein of <italic>T. gondii</italic> mAb (K97A) (Thermo Fisher Scientific Inc.), and anti-CD137 pAb (ab203391) (Abcam Plc., Waltham, USA).</p>
</sec>
<sec id="s2_5">
<title>Measurement of mRNA Expression in Liver and Spleen Tissues by Using Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)</title>
<p>Total RNA was extracted from about 100 mg of liver or spleen from each mouse using the MiniBEST Universal RNA Extraction Kit (9767, TaKaRa Bio, Inc., Shiga, Japan) according to the manufacturer&#x2019;s protocol. The quality of total RNA was analyzed by running 5 &#x3bc;l of each RNA sample on a 1.0% agarose gel stained with ethidium bromide. The quantity of total RNA was estimated by measuring the ratio of absorbance at 260 and 280 nm using a NanoDrop One spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA). First-strand cDNA was constructed from 1.5 &#x3bc;g of total RNA with oligo (dT) as primers using the PrimeScript&#x2122; II 1st Strand cDNA Synthesis Kit (6210A, TaKaRa Bio Inc.). The cDNA products were stored at &#x2212;80&#xb0;C for use. To determine the mRNA levels of <italic>T. gondii</italic> major surface antigen 1 (SAG1), IFN&#x3b3;, TNF&#x3b1;, IL-12p40, IL-4, IL-10, Gal-1, Gal-3, Gal-8, Gal-9, CD44, CD137, PDI, and Tim-3, qRT-PCR was performed using the SYBR<sup>&#xae;</sup> Premix Ex Taq&#x2122; II Kit (Tli RNaseH Plus) (RR820A, TaKaRa Bio Inc.) according to the manufacturer&#x2019;s instructions. The primer sequences are listed in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>. Briefly, a total of 20 &#x3bc;l reaction mixture contained 10 &#x3bc;l of SYBR<sup>&#xae;</sup> Premix Ex Taq&#x2122; II (2&#xd7;), 1 &#x3bc;l of each primer (8 &#x3bc;M), 6 &#x3bc;l of dH<sub>2</sub>O, and 2 &#x3bc;l of cDNA (0.2 &#x3bc;g/&#x3bc;l). Amplification was pre-denaturized for 30 s at 95&#xb0;C, followed by 40 cycles of 5 s at 95&#xb0;C and 30 s at 60&#xb0;C using a CFX96 Touch<sup>&#xae;</sup> Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA). Specific mRNA expression levels were normalized to that of the housekeeping gene, GAPDH, and the results are expressed as fold change compared to uninfected mice.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Primer sequences of genes used for quantitative real-time polymerase chain reaction assays.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Genes</th>
<th valign="top" align="center">Forward primers (5&#x2032;&#x2192;3&#x2032;)</th>
<th valign="top" align="center">Reverse primers (5&#x2032;&#x2192;3&#x2032;)</th>
<th valign="top" align="center">Accession No.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">SAG1</td>
<td valign="top" align="left">CTGTCAAGTTGTCTGCGGAAGGAC</td>
<td valign="top" align="left">CGTTAGCGTGGCACCATTATCACTC</td>
<td valign="top" align="left">MK250980.1</td>
</tr>
<tr>
<td valign="top" align="left">IFN&#x3b3;</td>
<td valign="top" align="left">GGAACTGGCAAAAGGATGGTGAC</td>
<td valign="top" align="left">GCTGGACCTGTGGGTTGTTGAC</td>
<td valign="top" align="left">NM_008337.4</td>
</tr>
<tr>
<td valign="top" align="left">TNF&#x3b1;</td>
<td valign="top" align="left">CCCTCACACTCAGATCATCTTCT</td>
<td valign="top" align="left">GCTACGACGTGGGCTACAG</td>
<td valign="top" align="left">AY423855.1</td>
</tr>
<tr>
<td valign="top" align="left">IL-12p40</td>
<td valign="top" align="left">CCTGGTTTGCCATCGTTTTG</td>
<td valign="top" align="left">TCAGAGTCTCGCCTCCTTTGTG</td>
<td valign="top" align="left">NM_001303244.1</td>
</tr>
<tr>
<td valign="top" align="left">IL-4</td>
<td valign="top" align="left">ACAGGAGAAGGGACGCCAT</td>
<td valign="top" align="left">GAAGCCCTACAGACGAGCTCA</td>
<td valign="top" align="left">NM_021283.2</td>
</tr>
<tr>
<td valign="top" align="left">IL-10</td>
<td valign="top" align="left">AGCCGGGAAGACAATAACTG</td>
<td valign="top" align="left">CATTTCCGATAAGGCTTGG</td>
<td valign="top" align="left">NM_010548.2</td>
</tr>
<tr>
<td valign="top" align="left">Gal-1</td>
<td valign="top" align="left">CGCCAGCAACCTGAATC</td>
<td valign="top" align="left">GTCCCATCTTCCTTGGTGTTA</td>
<td valign="top" align="left">NM_008495.2</td>
</tr>
<tr>
<td valign="top" align="left">Gal-3</td>
<td valign="top" align="left">GCTACTGGCCCCTTTGGT</td>
<td valign="top" align="left">CCAGGCAAGGGCATATCGTA</td>
<td valign="top" align="left">NM_001145953.1</td>
</tr>
<tr>
<td valign="top" align="left">Gal-8</td>
<td valign="top" align="left">GGGTGGTGGGTGGAACTG</td>
<td valign="top" align="left">GCCTTTGAGCCCCCAATATC</td>
<td valign="top" align="left">NM_001199043.1</td>
</tr>
<tr>
<td valign="top" align="left">Gal-9</td>
<td valign="top" align="left">GCAGGAGGGACTTCAGGTGA&#x2003;</td>
<td valign="top" align="left">GCCCCCACTGTCCGTTCT</td>
<td valign="top" align="left">NM_001159301.1</td>
</tr>
<tr>
<td valign="top" align="left">CD44</td>
<td valign="top" align="left">TGCAGGTATGGGTTCATAGAAGG</td>
<td valign="top" align="left">GTGTTGGACGTGACGAGGA</td>
<td valign="top" align="left">NM_001039150.1</td>
</tr>
<tr>
<td valign="top" align="left">CD137</td>
<td valign="top" align="left">CGTGCAGAACTCCTGTGATAAC</td>
<td valign="top" align="left">GTCCACCTATGCTGGAGAAGG</td>
<td valign="top" align="left">NM_001077508.1</td>
</tr>
<tr>
<td valign="top" align="left">PDI</td>
<td valign="top" align="left">CGCCTCCGATGTGTTGGAA</td>
<td valign="top" align="left">GAAGAACTCGACTAGCATGAGC</td>
<td valign="top" align="left">NM_007952.2</td>
</tr>
<tr>
<td valign="top" align="left">Tim-3</td>
<td valign="top" align="left">CCACGGAGAGAAATGGTTC</td>
<td valign="top" align="left">CATCAGCCCATGTGGAAAT</td>
<td valign="top" align="left">NM_134250.2</td>
</tr>
<tr>
<td valign="top" align="left">GAPDH</td>
<td valign="top" align="left">TTGATGGCAACAATCTCCAC</td>
<td valign="top" align="left">CGTCCCGTAGACAAAATGGT</td>
<td valign="top" align="left">BC023196.2</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_6">
<title>Western Blot Assay</title>
<p>Hepatic tissues were treated with RIPA lysis buffer (P0013B, Beyotime, Haimen, China), and lysate was incubated on ice for 30 min. After centrifugation at 10, 000 &#xd7; g for 5 min at 4&#xb0;C, the protein concentration of each lysate was determined using a BCA Protein Assay Kit (P0010S, Beyotime). Total protein (20 &#x3bc;g) from each sample was boiled in SDS-PAGE loading buffer under reducing conditions, run on a NuPAGE<sup>&#x2122;</sup> 4-12% Bis-Tris Protein Gel (NP0322BOX, Thermo Fisher Scientific Inc.), and transferred to PVDF membranes (FFP24, Beyotime). The membranes were blocked with QuickBlock<sup>&#x2122;</sup> blocking buffer (P0222, Beyotime) in PBSTw, probed with primary antibodies, and followed by application of horseradish peroxidase-conjugated secondary antibodies [goat anti-mouse (BA1050, Wuhan Boster Biological Engineering Co., Ltd.) or goat anti-rabbit (BA1054, Wuhan Boster Biological Engineering Co., Ltd.)]. The signal was revealed by BeyoECL Plus Kit (P0018S, Wuhan Boster Biological Engineering Co., Ltd.) and imaged using an Odyssey FC imaging system (LI-COR Biosciences, Lincoln, NE, USA).</p>
</sec>
<sec id="s2_7">
<title>Histopathological Analysis</title>
<p>For histological examination, the liver and spleen tissues were harvested and immediately fixed in 10% buffered formaldehyde (Guangzhou Chemical Reagent Factory, China) for 48 h. Five-micrometer-thick sections (50 or 100 &#x3bc;m distance between sections) of the organs from mice were stained with hematoxylin (1051740500, Sigma-Aldrich) and eosin (318906,  Sigma-Aldrich) solution to evaluate the histological changes. Sections, blinded for groups, were histopathologically evaluated under 20&#xd7; objective lens in five noncontiguous sections from 4 mice of each group. The semi-quantitative histopathological scores were determined based on previously described criteria (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B27">27</xref>) with modification. In brief, the histological changes were scored as 0, 1, 2, and 3 (absent, mild inflammation, moderate inflammation and necrosis, and severe inflammation and necrosis, respectively).</p>
</sec>
<sec id="s2_8">
<title>Ultrastructural Analysis</title>
<p>Tissue samples of livers and spleens of mice from different groups were fixed in 3% glutaraldehyde and 1% osmium tetroxide [both in 100 mM PBS, pH 7.2] before being dehydrated through a series of graded ethanol solutions. The fixed tissues were then embedded in SPI Pon 812 resin as instructed by the manufacture (02660-AB, Structure Probe Inc., West Chester, PA, USA). Ultrathin sections (70 nm) were cut from the embedded tissues using the Leica EM UC6 ultramicrotome (Leica Microsystems, Wetzlar, Germany) and mounted on formvar-coated grids. The sections were then stained for 15 min in aqueous 1% uranyl acetate followed by 0.2% lead citrate. Finally, samples were analyzed under a JEM100CX-II transmission electron microscope (JEOL Ltd., Tokyo, Japan) at an accelerating voltage of 100 kV.</p>
</sec>
<sec id="s2_9">
<title>Immunohistochemical Staining</title>
<p>Immunohistochemistry analysis was carried out using a Strept Avidin Biotin Complex (SABC)-alkaline phosphatase (AP) kit (SA1052, Wuhan Boster Biological Engineering Co., Ltd.). Liver sections (5 &#x3bc;m) of mice from different groups were deparaffinized and rehydrated in distilled water, followed by inactivating endogenous peroxidases with 3% hydrogen peroxide for 10 min at 37&#xb0;C. Heat-induced antigen retrieval was carried out in an 800 W microwave oven (Media, Shunde, China) for 30 min. Then, nonspecific binding was blocked by incubation in 5% bovine serum albumin in PBS (pH 7.4) for 20 min at room temperature. The sections were incubated with primary antibodies in a dilution of 1:200 overnight at 4&#xb0;C, and then incubated with the goat anti-rabbit IgG secondary antibody in the kit. Sections incubated with secondary antibodies were only used as isotype controls. Signals were detected with SABC-AP reagent, and developed using BCIP/NBT reagent. Finally, the sections were counterstained with hematoxylin (1051740500, Sigma-Aldrich) and imaged under a M8 slice scanner (Precipoint, Jena, Germany). Positive cells were identified by dark-brown staining, and quantified by using Image-Pro Plus (Image Z1 software, Media Cybernetics, MD, USA). The number of cells in each field was determined under high power field as well as the area of each field (0.177 mm<sup>2</sup>). The density of positive cells was expressed as cell number per square millimeter.</p>
</sec>
<sec id="s2_10">
<title>Immunofluorescence Assays</title>
<p>Liver sections (5 &#x3bc;m) were dewaxed firstly, and treated with antigen retrieval solution (P0088, Beyotime) according to the manufacture&#x2019;s protocol. Then the sections were blocked using Immunol Staining Blocking Buffer (P0102, Beyotime) at room temperature for 60 min. The fluorescence sections were incubated with primary antibody at room temperature for 60 min in a dark chamber, incubated with fluorescence labeling secondary antibody at room temperature for 60 min in a dark chamber, and then incubated with DAPI (ab228549, Abcam) for 30 min in a dark chamber. CD137<sup>+</sup> cells were marked by green fluorescent signals. The sections were observed under an EVOS FL autofluorescence microscope (Thermo Fisher Scientific Inc.), and positive cells were automatically counted by Image-pro Plus 6.0 (Media Cybernetics).</p>
</sec>
<sec id="s2_11">
<title>Statistical Analysis</title>
<p>Statistical analysis of the data was performed using Log-rank test, Wilcoxon rank sum test, Student&#x2019;s <italic>t</italic>-test, and one-way ANOVA followed by Bonferoni&#x2019;s multiple comparison tests using IBM SPSS Statistics version 22.0 (IBM Corp., Armonk, NY, USA). Pearson&#x2019;s correlation coefficient was used to analyze correlations between the levels of Gal-9, CD137, and IFN&#x3b3;. All graphs were generated using GraphPad Prism 8 (GraphPad software, San Diego, CA, USA). Data are presented as mean &#xb1; standard deviation (SD) at least three independent biological replicates. A value of <italic>P</italic> lower than 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Blockage of Galectin-Receptor Interactions Increased Survival Rate and Decreased Parasite Burden of <italic>T. gondii</italic>-Infected Mice</title>
<p>Mice were monitored daily after <italic>T. gondii</italic> infection. <italic>Tg-</italic>infected mice died between 7 and 9 days p.i., whereas <italic>Tg+</italic>lact mice died between 7 and 10 days p.i. Log-rank test showed that compared with <italic>Tg</italic>-infected mice, there was a significant increase of survival rate of <italic>Tg+</italic>lact mice (<italic>P</italic> &lt; 0.01, <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>). Compared with <italic>Tg-</italic>infected mice, <italic>T. gondii</italic> SAG1 mRNA expression level in the liver of <italic>Tg+</italic>lact mice was significantly decreased (<italic>P</italic> &lt; 0.01) (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>). Western blot assay confirmed that <italic>T. gondii</italic> p38 protein level was decreased in the liver tissue of <italic>Tg+</italic>lact mice in comparison of that of <italic>Tg-</italic>infected mice (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1C</bold></xref>). The results indicated that blockage of galectin-receptor interactions may contribute to host defense against acute <italic>T. gondii</italic> infection.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Survival rate and parasite burden. <bold>(A)</bold> Survival rate. <italic>Tg-</italic>infected mice (n = 11) died between days 7 and 9 p.i., while <italic>Tg</italic>+lact mice (n = 11) died between days 7 and 10 p.i. <bold>(B)</bold> Parasite burden in the liver tissues was estimated based on SAG1 mRNA level measured by qRT-PCR. Values are means from triplicate measurements, and data are shown as &#x2212; &#x394;&#x394;Ct values; two independent experiments were performed with four mice per group. **<italic>P</italic> &lt; 0.01. Y axis represents the mRNA relative expression level (REL) of different genes. <bold>(C)</bold> Parasite burden in the liver tissues was estimated based on the protein level of p38 from <italic>T. gondii</italic> detected by Western blot assay.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Blockage of Galectin-Receptor Interactions Attenuated Tissue Pathology of <italic>T. gondii</italic>-Infected Mice</title>
<p>To evaluate the effects of blockage of galectin-receptor interactions on tissue pathological changes, the liver and spleen tissues of mice from different groups were examined histologically (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>). No histological changes were observed in the liver and spleen tissues of uninfected mice injected with PBS or &#x3b1;-lactose. After <italic>T. gondii</italic> infection, severe damage with a great number of inflammatory foci of cell infiltrates including neutrophils, lymphocytes, and mononuclear cells were observed in the liver tissue of <italic>Tg-</italic>infected mice. In comparison, attenuated histological damage was observed in the liver tissue of <italic>Tg+</italic>lact mice. Compared with <italic>Tg-</italic>infected mice, semi-quantitative histopathological score based on pathological changes in the liver was significantly decreased in <italic>Tg+</italic>lact mice (<italic>P</italic> &lt; 0.05, <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>). There were a large amount of infiltrated inflammatory cells and tachyzoites observed in the spleens of <italic>Tg-</italic>infected mice and <italic>Tg+</italic>lact mice, and lots of lymphocytes were intruded into the red pulps, which led to the boundary between the white pulp and red pulp blurred (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>). However, the semi-quantitative histopathological scores in the spleens between <italic>Tg-</italic>infected mice and <italic>Tg+</italic>lact mice had no significant difference (<italic>P</italic> &gt; 0.05, <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The liver and spleen histopathology of mice from different groups. Mice were i.p. inoculated with 10<sup>2</sup> tachyzoites of <italic>T. gondii</italic> and killed at day 7 p.i. <bold>(A)</bold> Representative microscopic pictures showed tissue sections stained with H&amp;E from different groups. Original magnification 50&#xd7; (scale bar = 200 &#xb5;m) of the large image; the small image is 1000&#xd7; (scale bar = 20 &#x3bc;m). Yellow arrows indicate <italic>T. gondii</italic> tachyzoites. <bold>(B)</bold> Histopathological score analysis of the liver and spleen tissues. Data are represented as mean &#xb1; SD. There were 4 mice per group, and the data are representative of two experiments. *<italic>P</italic> &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g002.tif"/>
</fig>
<p>Transmission electron microscopy (TEM) was used to reveal the subcellular structures of the liver and spleen tissues from the two <italic>T. gondii</italic>-infected groups <bold>(</bold>
<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref><bold>)</bold>. Cellular organelles, such as mitochondria and endoplasmic reticulum (ER) in the hepatocytes of <italic>Tg-</italic>infected mice, became swollen and deformed. In addition, neutrophils, Kupffer cells (KCs), and numerous <italic>T. gondii</italic> tachyzoites were observed in the liver tissue of this group. Similar subcellular structure changes of hepatocytes were observed in the liver of <italic>Tg+</italic>lact mice, however, the lesion was less severe and fewer <italic>T. gondii</italic> tachyzoites were observed in the liver tissue. In the necrosis area of spleen tissue of <italic>Tg-</italic>infected mice, cell membranes and intercellular connections were damaged, and normal host cells were hardly observed. In addition, there were numerous extracellular <italic>T. gondii</italic> tachyzoites observed by TEM. However, the damage of ultrastructure of the spleen tissue of <italic>Tg+</italic>lact mice was less severe. The number of tachyzoites was fewer, and most of them were inside intracellular parasitophorous vacuoles (PVs) of the spleen tissue cells rather than egressed into extracellular space of the tissue.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The ultrastructure of the livers and spleens in <italic>T. gondii</italic>-infected mice with or without &#x3b1;-lactose treatment. Blue stars indicate <italic>T. gondii</italic> tachyzoites, blue rectangles indicate the accumulation areas of tachyzoites, and red circles indicate the large necrosis areas. N, nucleus; ER, endoplasmic reticulum; Mt, mitochondrion; Ne, neutrophil; KC, Kupffer cell; PV, parasitophorous vacuole.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Blockage of Galectin-Receptor Interactions Increased CD137 Expression in the Liver of <italic>T. gondii</italic>-Infected Mice</title>
<p>The mRNA expression levels of Gal-1, Gal-3, Gal-8, and Gal-9 (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4A</bold></xref>), and Gal-9 receptors (CD44, CD137, PDI, and Tim-3) (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4B</bold></xref>) in the livers of <italic>Tg</italic>-infected mice and <italic>Tg</italic>+lact mice were examined by using qRT-PCR and presented as heatmaps. The most conspicuous upregulation values were found for Gal-9 and its receptor CD137. Compared with uninfected mice, the mRNA levels of Gal-9 (<italic>P</italic> &lt; 0.01) and CD137 (<italic>P</italic> &lt; 0.001 and <italic>P</italic> &lt; 0.05, respectively) were significantly increased in the liver and spleen of <italic>Tg-</italic>infected mice, and the levels of Gal-9 (<italic>P</italic> &lt; 0.05 and <italic>P</italic> &lt; 0.01, respectively) and CD137 (<italic>P</italic> &lt; 0.01) were significantly increased in the liver and spleen of <italic>Tg</italic>+lact mice. Compared with <italic>Tg-</italic>infected mice, the mRNA levels of CD137 in the liver and Gal-9 in the spleen of <italic>Tg</italic>+lact mice were significantly increased (<italic>P</italic> &lt; 0.01, <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4C</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Gal-9 and its receptor CD137 were upregulated during <italic>T. gondii</italic> infection. Heatmap visualization showed the mRNA expressions of Gal-1, Gal-3, Gal-8, and Gal-9 <bold>(A)</bold> and the receptors of Gal-9 (CD44, CD137, PDI, and Tim-3) <bold>(B)</bold> in the livers of <italic>Tg</italic>-infected mice and <italic>Tg</italic>+lact mice, while histograms showed the expression levels of Gal-9 and CD137 in the livers and spleens of mice from different groups <bold>(C)</bold>. Liver and spleen tissues were collected on day 7 p.i. for evaluating mRNA expression levels by using qRT-PCR. Values are means from triplicate measurements, and data are presented as means &#xb1; SD; two independent experiments were performed with four mice per group. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, and ***<italic>P</italic> &lt; 0.001. Y axis represents the mRNA relative expression level (REL) of different genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g004.tif"/>
</fig>
<p>Immunofluorescence assay showed that there were only a few of CD137<sup>+</sup> cells observed in the liver tissue of uninfected mice (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5A</bold></xref>). However, compared with uninfected mice, the numbers of CD137<sup>+</sup> cells in the livers of both <italic>Tg</italic>-infected mice and <italic>Tg+</italic>lact mice were significantly increased (<italic>P</italic> &lt; 0.001). Compared with <italic>Tg</italic>-infected mice, the number of CD137<sup>+</sup> cells in the liver of <italic>Tg+</italic>lact mice was significantly increased (<italic>P</italic> &lt; 0.01, <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5B</bold></xref>). Western blot assay confirmed that the protein level of CD137 in the liver tissue of <italic>Tg+</italic>lact mice was increased compared with that of <italic>Tg-</italic>infected mice (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5C</bold></xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>CD137<sup>+</sup> cells in the liver tissues of mice from different groups. <bold>(A)</bold> Immunofluorescence staining showed CD137<sup>+</sup> cells (labeled green) in the livers of mice. Original magnification 200&#xd7; (scale bar = 100 &#xb5;m). <bold>(B)</bold> Morphometric analysis in liver tissues by showing the number of CD137<sup>+</sup> cells per square millimeter. Data are presented as means &#xb1; SD; experiments were performed with four mice per group. **<italic>P</italic> &lt; 0.01, and ***<italic>P</italic> &lt; 0.001. <bold>(C)</bold> The protein levels of CD137 in the livers of mice were detected by Western blot assay.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g005.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Blockage of Galectin-Receptor Interactions Up-Regulated mRNA Expressions of IFN&#x3b3;, IL-4, and IL-10 in the Liver of <italic>T. gondii</italic>-Infected Mice</title>
<p>The effects of &#x3b1;-lactose treatment on Th1 and Th2 cytokine responses during <italic>T. gondii</italic> infection were evaluated by measuring the mRNA expression levels of IFN&#x3b3;, TNF&#x3b1;, IL-12p40, IL-4, and IL-10 in the livers and spleens of mice from different groups. Compared with uninfected mice, there were significantly increased mRNA expression levels of IFN&#x3b3; (<italic>P</italic> &lt; 0.001 and <italic>P</italic> &lt; 0.05, respectively), TNF&#x3b1; (<italic>P</italic> &lt; 0.05), IL-12p40 (<italic>P</italic> &lt; 0.01), and IL-4 (<italic>P</italic> &lt; 0.05) in the liver and spleen of <italic>Tg</italic>-infected mice, and significantly increased IL-10 level (<italic>P</italic> &lt; 0.001) in the liver of <italic>Tg</italic>-infected mice on day 7 p.i.; significantly increased levels of IFN&#x3b3; (<italic>P</italic> &lt; 0.01), TNF&#x3b1; (<italic>P</italic> &lt; 0.01 and <italic>P</italic> &lt; 0.05, respectively), IL-12p40 (<italic>P</italic> &lt; 0.01 and <italic>P</italic> &lt; 0.05, respectively), IL-4 (<italic>P</italic> &lt; 0.001), and IL-10 (<italic>P</italic> &lt; 0.01 and <italic>P</italic> &lt; 0.001, respectively) in the liver and spleen of <italic>Tg</italic>+lact mice on day 7 p.i. However, compared with <italic>Tg</italic>-infected mice, there were significantly increased IFN&#x3b3; level (<italic>P</italic> &lt; 0.01) in the liver, and significantly increased levels of IL-4 (<italic>P</italic> &lt; 0.001) and IL-10 (<italic>P</italic> &lt; 0.01) in the liver and spleen of <italic>Tg</italic>+lact mice on day 7 p.i. The results indicated that blockage of galectin-receptor interactions may increase both Th1 and Th2 responses in the liver of <italic>T. gondii</italic>-infected mice (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6</bold></xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>The mRNA expression levels of Th1 and Th2 cytokines in the livers <bold>(A)</bold> and spleens <bold>(B)</bold> of mice from different groups on day 7 p.i. Values are means from triplicate measurements, and data are presented as means &#xb1; SD; two independent experiments were performed with four mice per group. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, and ***<italic>P</italic> &lt; 0.001. Y axis represents the mRNA relative expression level (REL) of different genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g006.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Correlations Between Gal-9 and CD137, Gal-9 and IFN&#x3b3;, and CD137 and IFN&#x3b3; in the Liver and Spleen of <italic>Tg</italic>-Infected Mice or <italic>Tg</italic>+Lact Mice</title>
<p>The correlations between the mRNA levels of Gal-9 and CD137, Gal-9 and IFN&#x3b3;, and CD137 and IFN&#x3b3; in the liver and spleen of <italic>Tg</italic>-infected mice or <italic>Tg</italic>+lact mice were evaluated, herein only significant correlations were presented. In <italic>Tg</italic>-infected mice, there were significant correlations between the mRNA levels of Gal-9 and CD137 (<italic>r</italic> = 0.986, <italic>P</italic> = 0.014), Gal-9 and IFN&#x3b3; (<italic>r</italic> = 0.991, <italic>P</italic> = 0.009), and CD137 and IFN&#x3b3; (<italic>r</italic> = 0.998, <italic>P</italic> = 0.002) in the liver (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7A</bold></xref>), and significant positive correlations between the mRNA levels of Gal-9 and CD137 (<italic>r</italic> = 0.990, <italic>P</italic> = 0.010), Gal-9 and IFN&#x3b3; (<italic>r</italic> = 0.997, <italic>P</italic> = 0.003), and CD137 and IFN&#x3b3; (<italic>r</italic> = 0.976, <italic>P</italic> = 0.024) in the spleen (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7B</bold></xref><bold>)</bold>. In <italic>Tg</italic>+lact mice, there was significant correlation between the mRNA levels of CD137 and IFN&#x3b3; (<italic>r</italic> = 0.955, <italic>P</italic> = 0.045) in the liver (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7C</bold></xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Correlation analysis between the mRNA expression levels detected in the livers and spleens of <italic>Tg</italic>-infected mice or <italic>Tg</italic>+lact mice (n = 4). <bold>(A)</bold> Significant correlations between Gal-9 and CD137, Gal-9 and IFN&#x3b3;, and CD137 and IFN&#x3b3; in the liver, and <bold>(B)</bold> Significant correlations between Gal-9 and CD137, Gal-9 and IFN&#x3b3;, and CD137 and IFN&#x3b3; in the spleen of <italic>Tg</italic>-infected mice. <bold>(C)</bold> Significant correlation between CD137 and IFN&#x3b3; in the liver of <italic>Tg</italic>+lact mice. The <italic>r</italic> value generates for the theoretical line of best fit, while the <italic>P</italic> value indicates the significance of the correlation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g007.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>Blockage of Galectin-Receptor Interactions Promoted M2 Macrophage Polarization in the Liver of <italic>T. gondii</italic>-Infected Mice</title>
<p>Macrophages are a major player in defense against pathogens in the liver. In uninfected mice, only a few macrophages (stained brown) were observed in the liver tissue when using CD86 and CD206 as the immunohistochemical labels for M1 and M2 macrophages, respectively (<xref ref-type="fig" rid="f8"><bold>Figure&#xa0;8A</bold></xref>). Compared with uninfected mice, the numbers of CD86<sup>+</sup> macrophages in the livers of <italic>Tg</italic>-infected and <italic>Tg</italic>+lact mice were significantly increased (<italic>P</italic> &lt; 0.001). However, there was no significant difference between the two <italic>T. gondii</italic>-infected groups (<italic>P</italic> &gt; 0.05). Compared with uninfected mice, the numbers of CD206<sup>+</sup> macrophages in the livers of <italic>Tg</italic>-infected mice and <italic>Tg</italic>+lact mice were significantly increased (<italic>P</italic> &lt; 0.001). Compared with <italic>Tg-</italic>infected mice, the number of CD206<sup>+</sup> macrophages in the liver of <italic>Tg+</italic>lact mice was significantly increased (<italic>P &lt;</italic> 0.001, <xref ref-type="fig" rid="f8"><bold>Figure&#xa0;8B</bold></xref>). The results indicated that blockage of galectin-receptor interactions may induce M2 macrophage polarization in the liver of <italic>T. gondii</italic>-infected mice.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Immunohistochemical staining for CD86<sup>+</sup> and CD206<sup>+</sup> cells in the livers of mice from different groups. <bold>(A)</bold> Immunohistochemical staining of CD86<sup>+</sup> and CD206<sup>+</sup> cells were labeled by CD86 mAb and CD206 pAb, respectively. Red arrows indicate positive cells and black arrows indicate tachyzoites. Original magnification 200&#xd7; (scale bar = 100 &#xb5;m). <bold>(B)</bold> Morphometric analysis showed the number of CD86<sup>+</sup> or CD206<sup>+</sup> cells per square millimeter in the liver tissues. Data are presented as means &#xb1; SD; experiments were performed with four mice per group. ***<italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-896744-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>As an opportunistic protozoan, chronic infection with <italic>T. gondii</italic> is likely one of the most common infections in humans. Most <italic>T. gondii</italic> infections show minimal symptoms, but immunocompromised patients tend to have a poor prognosis (<xref ref-type="bibr" rid="B28">28</xref>). Clinical disease can also occur in immunocompetent adults, in particular manifesting as ocular toxoplasmosis (<xref ref-type="bibr" rid="B29">29</xref>). In liver, <italic>T. gondii</italic> has been associated with a number of pathological changes including hepatomegaly, granuloma, hepatitis, and necrosis (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). A case report showed that a child suffered from acquired toxoplasmosis with a rare manifestation of severe liver damage (<xref ref-type="bibr" rid="B32">32</xref>). In the present study, our data showed that blockage of galectin-receptor interactions could prolong the survival time, decrease liver parasite burden, and attenuate liver pathology of <italic>T. gondii</italic>-infected mice.</p>
<p><italic>T. gondii</italic> infection induces Th1-biased immune response, which is crucial for resistance against toxoplasmosis (<xref ref-type="bibr" rid="B33">33</xref>). It has been reported that extensive liver damage is accompanied the elevated levels of Th1 cytokines (<xref ref-type="bibr" rid="B34">34</xref>). In the present study, <italic>T. gondii</italic>-infected C57BL/6 mice showed high parasite burden and strong inflammatory outcome in the liver, accompanied with a dominant Th1 response characterized with high expression levels of Th1 cytokines (IFN&#x3b3;, TNF&#x3b1;, and IL-12p40) in the liver tissue after <italic>T. gondii</italic> infection; while <italic>T. gondii-</italic>infected mice treated with &#x3b1;-lactose showed prolonged survival time, decreased tissue parasite burden, and attenuated liver histopathology, accompanied with higher mRNA expression levels of CD137, IFN&#x3b3;, IL-4, and IL-10, and enhanced M2 macrophage polarization in the liver. It has been reported that increased IFN&#x3b3; production may effectively promote parasite clearance for its pivotal role in driving immune responses against <italic>T. gondii</italic> (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). IL-4 and IL-10 can decrease parasite load in <italic>T. gondii</italic>-infected mice treated with the mast cell degranulation inhibitor disodium cromoglycate (<xref ref-type="bibr" rid="B8">8</xref>), and IL-10 is required for control of necrosis and immune-mediated pathology during <italic>T. gondii</italic> infection (<xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>). M1 and M2 macrophages can be converted into each other in certain microenvironments (<xref ref-type="bibr" rid="B40">40</xref>), and M2 phenotype macrophages are believed to play important roles in control of parasites, such as <italic>Trypanosoma cruzi, Trichinella spiralis</italic>, and <italic>Schistosoma mansoni</italic>, by producing IL-4, IL-10, chitinase-3-like protein 3 (Ym1), and arginase-1 (Arg-1) (<xref ref-type="bibr" rid="B41">41</xref>&#x2013;<xref ref-type="bibr" rid="B43">43</xref>). Previous study by our group has demonstrated the important role of M2 phenotype markers Arg-1 and Ym1 during toxoplasmic encephalitis (TE) in <italic>T. gondii</italic>-susceptible C57BL/6 mice (<xref ref-type="bibr" rid="B44">44</xref>). <italic>Toxo</italic>ROP16<sub>I/III</sub> promotes the polarization of M2 cells, and enhances the synthesis of Arg-1, IL-10, transforming growth factor-&#x3b2;1, and IL-13, which may ameliorate the pathogenesis of inflammatory bowel disease in an <italic>in vitro</italic> experimental model (<xref ref-type="bibr" rid="B45">45</xref>). In this study, the increased IFN&#x3b3;, IL-4, and IL-10 expression levels, and increased M2 macrophage numbers induced by blockage of galectin-receptor interactions may be one of the reasons that <italic>Tg</italic>+lact mice had lower parasite burden and attenuated liver histopathology than those of <italic>Tg</italic>-infected mice. Our data suggested that blockage of galectin-receptor interactions may have a potential beneficial effect on acute <italic>T. gondii</italic> infection.</p>
<p>Galectins, a conserved group of immunomodulatory animal lectins, are widely expressed in different tissues and a number of immune cell populations (<xref ref-type="bibr" rid="B46">46</xref>), and are involved in lots of physiological functions, such as inflammation, immune responses, cell migration, autophagy, and signaling (<xref ref-type="bibr" rid="B47">47</xref>). So far 15 galectins have been identified in mammals (<xref ref-type="bibr" rid="B48">48</xref>). Gal-9 is widely expressed in various tissues such as spleen, lung, heart, and thymus, and is particularly abundant in the liver tissue (<xref ref-type="bibr" rid="B49">49</xref>). Gal-9 involves in a variety of pathological processes including autoimmunity, fibrosis, and cancer (<xref ref-type="bibr" rid="B50">50</xref>), as well as regulation of inflammation (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B51">51</xref>). Studies in our group have found that galectins may contribute to severe egg granulomatous inflammation and tissue fibrosis in the liver, spleen, and large intestine of <italic>Schistosoma japonicum</italic>-infected mice (<xref ref-type="bibr" rid="B52">52</xref>). Both Gal-3 and Gal-9 are important factors in TE-susceptible C57BL/6 mice and TE-resistant BALB/c mice infected with <italic>T. gondii</italic> Prugniaud strain (<xref ref-type="bibr" rid="B44">44</xref>). Blockage of galectin-receptor interactions could lead to elevated heart eosinophil recruitment, exacerbated heart pathology and fibrosis, and functional damage to the heart during acute <italic>T. spiralis</italic> infection in a murine model (<xref ref-type="bibr" rid="B53">53</xref>). In addition, blockage of galectin-receptor interactions leads to decreased host survival rate, increased peripheral blood parasitemia, increased parasite burden in the liver, and increased CD68<sup>+</sup> macrophages and exacerbated liver pathology of <italic>Plasmodium berghei</italic>-infected mice (<xref ref-type="bibr" rid="B54">54</xref>). However, Gal-9 was also found to be upregulated in inflamed tissues, suggesting that Gal-9 may be closely related to inflammatory development under infectious or autoimmune conditions (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B55">55</xref>). In the present study, the mRNA expression levels of Gal-1, Gal-3, Gal-8, and Gal-9 were measured in the liver of <italic>T. gondii</italic>-infected mice, and Gal-9 showed the most conspicuous upregulation. Our data revealed that blocking galectin-receptor interactions exhibited decreased parasite burden, elevated M2 macrophage population, up-regulated Th2 cytokines, and alleviated liver pathology in <italic>T. gondii</italic>-infected mice. Therefore, Gal-9 may play a diverse role during acute <italic>T. gondii</italic> infection, and blockage of Gal-9-receptor interaction may have a potential role for attenuating toxoplasmic liver damage.</p>
<p>Among the receptors of Gal-9, Tim-3 has been well studied for its critical role in the immune regulation during <italic>T. gondii</italic> infection (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). However, the other three receptors, CD137 (<xref ref-type="bibr" rid="B14">14</xref>), CD44 (<xref ref-type="bibr" rid="B15">15</xref>), and PDI (<xref ref-type="bibr" rid="B16">16</xref>) are rarely investigated. In the present study, our data showed that the upregulation value of CD137 was markedly higher than those of CD44, PDI, and Tim-3 in the liver of <italic>T. gondii</italic>-infected mice. In addition, the mRNA level and protein level of CD137, and the numbers of CD137 positive cells in the liver of <italic>Tg</italic>+lact mice were all higher than those of <italic>Tg</italic>-infected mice. As an important co-stimulatory molecule functioning in T cells, dendritic cells, and natural killer cells (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B58">58</xref>), CD137 preferentially induces Th1 response by increasing IFN&#x3b3; and CD8<sup>+</sup> T cell proliferation through interacting with CD137L (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). Our previous data showed upregulation of CD137 expression in experimental ocular toxoplasmosis (<xref ref-type="bibr" rid="B20">20</xref>). Here, our results further demonstrated the positive correlation between CD137 and IFN&#x3b3; in the livers of <italic>Tg</italic>-infected mice and <italic>Tg</italic>+lact mice, suggesting that Gal-9-CD137 pathway may regulate T cell immune responses during acute <italic>T. gondii</italic> infection.</p>
<p>In conclusion, our study has provided evidence that galectin-receptor interactions, especially Gal-9-CD137 signaling, is important for the regulation of T cell and macrophage functions, which may play a role during <italic>T. gondii</italic> infection. Further studies are necessary for a more detailed understanding of the mechanisms.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>Animal studies were conducted according to protocols approved by the Animal Experimentation Ethics Committee of Zhongshan School of Medicine on Laboratory Animal Care at Sun Yat-sen University, China.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author Contributions</title>
<p>FL conceived and designed the experiments. JH and YH performed the experiments. JH and FL analyzed the data. FL and JH wrote the manuscript. All authors approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (81971955), the Natural Science Foundation of Guangdong Province (2019A1515011667, 2021A1515012115), and 2021 Graduate Education Innovation Plan Project of Guangdong Province (2021SFKC003).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Vermont</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Cotton</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hill-Cawthorne</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Konen-Waisman</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparative Genomics of the Apicomplexan Parasites <italic>Toxoplasma Gondii</italic> and <italic>Neospora Caninum</italic>: Coccidia Differing in Host Range and Transmission Strategy</article-title>. <source>PLoS Pathog</source> (<year>2012</year>) <volume>8</volume>(<issue>3</issue>):<fpage>22</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1002567</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milne</surname> <given-names>G</given-names>
</name>
<name>
<surname>Webster</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title><italic>Toxoplasma Gondii</italic>: An Underestimated Threat</article-title>? <source>Trends Parasitol</source> (<year>2020</year>) <volume>36</volume>(<issue>12</issue>):<page-range>959&#x2013;69</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.pt.2020.08.005</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waldman</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Schwarz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wadsworth</surname> <given-names>MH</given-names> <suffix>2nd</suffix>
</name>
<name>
<surname>Saeij</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Shalek</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Lourido</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Identification of a Master Regulator of Differentiation in <italic>Toxoplasma</italic>
</article-title>. <source>Cell</source> (<year>2020</year>) <volume>180</volume>(<issue>2</issue>):<fpage>359</fpage>&#x2013;<lpage>72.e316</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2019.12.013</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marra</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Central Nervous System Infection With <italic>Toxoplasma Gondii</italic>
</article-title>. <source>Handb Clin Neurol</source> (<year>2018</year>) <volume>152</volume>:<page-range>117&#x2013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-444-63849-6.00009-8</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Do&#x11f;an</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kabuk&#xe7;uo&#x11f;lu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vardareli</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Toxoplasmic Hepatitis in an Immunocompetent Patient</article-title>. <source>Turkiye Parazitol Derg</source> (<year>2007</year>) <volume>31</volume>(<issue>4</issue>):<page-range>260&#x2013;3</page-range>.</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pazoki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ziaee</surname> <given-names>M</given-names>
</name>
<name>
<surname>Anvari</surname> <given-names>D</given-names>
</name>
<name>
<surname>Rezaei</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ahmadpour</surname> <given-names>E</given-names>
</name>
<name>
<surname>Haghparast-kenari</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title><italic>Toxoplasma Gondii</italic> Infection as a Potential Risk for Chronic Liver Diseases: A Systematic Review and Meta-Analysis</article-title>. <source>Microb Pathog</source> (<year>2020</year>) <volume>149</volume>:<fpage>104578</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micpath.2020.104578</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dupont</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Christian</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Hunter</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>Immune Response and Immunopathology During Toxoplasmosis</article-title>. <source>Semin Immunopathol</source> (<year>2012</year>) <volume>34</volume>(<issue>6</issue>):<fpage>793</fpage>&#x2013;<lpage>813</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00281-012-0339-3</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lun</surname> <given-names>ZR</given-names>
</name>
<etal/>
</person-group>. <article-title>Mast Cells Modulate Acute Toxoplasmosis in Murine Models</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>10</issue>):<elocation-id>e77327</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0077327</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barondes</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Cooper</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Gitt</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Leffler</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Galectins. Structure and Function of a Large Family of Animal Lectins</article-title>. <source>J Biol Chem</source> (<year>1994</year>) <volume>269</volume>(<issue>33</issue>):<page-range>20807&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0021-9258(17)31891-4</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>FT</given-names>
</name>
<name>
<surname>Rabinovich</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>Galectins: Regulators of Acute and Chronic Inflammation</article-title>. <source>Ann N Y Acad Sci</source> (<year>2010</year>) <volume>1183</volume>:<page-range>158&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05131.x</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moar</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tandon</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Galectin-9 as a Biomarker of Disease Severity</article-title>. <source>Cell Immunol</source> (<year>2021</year>) <volume>361</volume>:<fpage>104287</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cellimm.2021.104287</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabatos</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Chakravarti</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cha</surname> <given-names>E</given-names>
</name>
<name>
<surname>Schubart</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sanchez-Fueyo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>XX</given-names>
</name>
<etal/>
</person-group>. <article-title>Interaction of Tim-3 and Tim-3 Ligand Regulates T Helper Type 1 Responses and Induction of Peripheral Tolerance</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>(<issue>11</issue>):<page-range>1102&#x2013;10</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni988</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Schubart</surname> <given-names>A</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>H</given-names>
</name>
<name>
<surname>Imitola</surname> <given-names>J</given-names>
</name>
<name>
<surname>Khoury</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>The Tim-3 Ligand Galectin-9 Negatively Regulates T Helper Type 1 Immunity</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>(<issue>12</issue>):<page-range>1245&#x2013;52</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni1271</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madireddi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Eun</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Nemcovicova</surname> <given-names>I</given-names>
</name>
<name>
<surname>Mehta</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Zajonc</surname> <given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>Galectin-9 Controls the Therapeutic Activity of 4-1BB-Targeting Antibodies</article-title>. <source>J Exp Med</source> (<year>2014</year>) <volume>211</volume>(<issue>7</issue>):<page-range>1433&#x2013;48</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20132687</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Thalhamer</surname> <given-names>T</given-names>
</name>
<name>
<surname>Franca</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hotta</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>(<issue>2</issue>):<page-range>270&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.011</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>B</given-names>
</name>
<name>
<surname>Baum</surname> <given-names>LG</given-names>
</name>
</person-group>. <article-title>Galectin-9 Binding to Cell Surface Protein Disulfide Isomerase Regulates the Redox Environment to Enhance T-Cell Migration and HIV Entry</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2011</year>) <volume>108</volume>(<issue>26</issue>):<page-range>10650&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1017954108</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thijssen</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Hulsmans</surname> <given-names>S</given-names>
</name>
<name>
<surname>Griffioen</surname> <given-names>AW</given-names>
</name>
</person-group>. <article-title>The Galectin Profile of the Endothelium: Altered Expression and Localization in Activated and Tumor Endothelial Cells</article-title>. <source>Am J Pathol</source> (<year>2008</year>) <volume>172</volume>(<issue>2</issue>):<page-range>545&#x2013;53</page-range>. doi: <pub-id pub-id-type="doi">10.2353/ajpath.2008.070938</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katoh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ishii</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nobumoto</surname> <given-names>A</given-names>
</name>
<name>
<surname>Takeshita</surname> <given-names>K</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Shinonaga</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Galectin-9 Inhibits CD44-Hyaluronan Interaction and Suppresses a Murine Model of Allergic Asthma</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2007</year>) <volume>176</volume>(<issue>1</issue>):<fpage>27</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.200608-1243OC</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname> <given-names>K</given-names>
</name>
<name>
<surname>Webb</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hernandez-Davies</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>KP</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Galectin-9 Binds to O-Glycans on Protein Disulfide Isomerase</article-title>. <source>Glycobiology</source> (<year>2017</year>) <volume>27</volume>(<issue>9</issue>):<page-range>878&#x2013;87</page-range>. doi: <pub-id pub-id-type="doi">10.1093/glycob/cwx065</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>YX</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>FL</given-names>
</name>
</person-group>. <article-title>Galectins Expressed Differently in Genetically Susceptible C57BL/6 and Resistant BALB/c Mice During Acute Ocular <italic>Toxoplasma Gondii</italic> Infection</article-title>. <source>Parasitology</source> (<year>2017</year>) <volume>144</volume>(<issue>8</issue>):<page-range>1064&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1017/S0031182017000270</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortego</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Robey</surname> <given-names>B</given-names>
</name>
<name>
<surname>Morrison</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Toxoplasmic Chorioretinitis and Hepatic Granulomas</article-title>. <source>Am J Gastroenterol</source> (<year>1990</year>) <volume>85</volume>(<issue>10</issue>):<page-range>1418&#x2013;20</page-range>.</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lodha</surname> <given-names>R</given-names>
</name>
<name>
<surname>Passi</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Bhan</surname> <given-names>MK</given-names>
</name>
</person-group>. <article-title>Cholestatic Jaundice Due to Congenital <italic>Toxoplasma Gondii</italic> Infection</article-title>. <source>Indian J Pediatr</source> (<year>1998</year>) <volume>65</volume>(<issue>1</issue>):<page-range>154&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1007/BF02849711</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ustun</surname> <given-names>S</given-names>
</name>
<name>
<surname>Aksoy</surname> <given-names>U</given-names>
</name>
<name>
<surname>Dagci</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ersoz</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Incidence of Toxoplasmosis in Patients With Cirrhosis</article-title>. <source>World J Gastroenterol</source> (<year>2004</year>) <volume>10</volume>(<issue>3</issue>):<page-range>452&#x2013;4</page-range>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v10.i3.452</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golden-Mason</surname> <given-names>L</given-names>
</name>
<name>
<surname>Rosen</surname> <given-names>HR</given-names>
</name>
</person-group>. <article-title>Galectin-9: Diverse Roles in Hepatic Immune Homeostasis and Inflammation</article-title>. <source>Hepatology</source> (<year>2017</year>) <volume>66</volume>(<issue>1</issue>):<page-range>271&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1002/hep.29106</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sehrawat</surname> <given-names>S</given-names>
</name>
<name>
<surname>Reddy</surname> <given-names>PBJ</given-names>
</name>
<name>
<surname>Rajasagi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Suryawanshi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hirashima</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rouse</surname> <given-names>BT</given-names>
</name>
</person-group>. <article-title>Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8 T Cell Response</article-title>. <source>PLoS Pathog</source> (<year>2010</year>) <volume>6</volume>(<issue>5</issue>):<elocation-id>e1000882</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1000882</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vega-Carrascal</surname> <given-names>I</given-names>
</name>
<name>
<surname>Reeves</surname> <given-names>EP</given-names>
</name>
<name>
<surname>McElvaney</surname> <given-names>NG</given-names>
</name>
</person-group>. <article-title>The Role of TIM-Containing Molecules in Airway Disease and Their Potential as Therapeutic Targets</article-title>. <source>J Inflamm Res</source> (<year>2012</year>) <volume>5</volume>:<fpage>77</fpage>&#x2013;<lpage>87</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/jir.s34225</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Upregulated Expression of Tim-3 Involved in the Process of Toxoplasmic Encephalitis in Mouse Model</article-title>. <source>Parasitol Res</source> (<year>2013</year>) <volume>112</volume>(<issue>7</issue>):<page-range>2511&#x2013;21</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00436-013-3416-1</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ortiz Lopez</surname> <given-names>HIA</given-names>
</name>
<name>
<surname>P&#xe9;rez</surname> <given-names>GE</given-names>
</name>
<name>
<surname>Burgos</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Farina</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Saldarriaga</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Toxoplasmosis and the Heart</article-title>. <source>Curr Probl Cardiol</source> (<year>2021</year>) <volume>46</volume>(<issue>3</issue>):<fpage>100741</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cpcardiol.2020.100741</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Dubey</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Toxoplasmosis: A History of Clinical Observations</article-title>. <source>Int J Parasitol</source> (<year>2009</year>) <volume>39</volume>(<issue>8</issue>):<fpage>895</fpage>&#x2013;<lpage>901</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijpara.2009.02.004</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassan</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Farghaly</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Gaber</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Nageeb</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Hegab</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Galal</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Parasitic Causes of Hepatomegaly in Children</article-title>. <source>J Egypt Soc Parasitol</source> (<year>1996</year>) <volume>26</volume>(<issue>1</issue>):<page-range>177&#x2013;89</page-range>.</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mastroianni</surname> <given-names>A</given-names>
</name>
<name>
<surname>Coronado</surname> <given-names>O</given-names>
</name>
<name>
<surname>Scarani</surname> <given-names>P</given-names>
</name>
<name>
<surname>Manfredi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chiodo</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Liver Toxoplasmosis and Acquired Immunodeficiency Syndrome</article-title>. <source>Recenti Prog Med</source> (<year>1996</year>) <volume>87</volume>(<issue>7-8</issue>):<page-range>353&#x2013;5</page-range>.</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garty</surname> <given-names>I</given-names>
</name>
<name>
<surname>Tal</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kaynan</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Tc-99m Colloid Lung Uptake in a Rare Case of Toxoplasmosis With Liver Involvement</article-title>. <source>Clin Nucl Med</source> (<year>1984</year>) <volume>9</volume>(<issue>6</issue>):<page-range>310&#x2013;3</page-range>. doi: <pub-id pub-id-type="doi">10.1097/00003072-198406000-00002</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Remington</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>The Effect of Anti-IFN-Gamma Antibody on the Protective Effect of Lyt-2+ Immune T Cells Against Toxoplasmosis in Mice</article-title>. <source>J Immunol</source> (<year>1990</year>) <volume>144</volume>(<issue>5</issue>):<page-range>1954&#x2013;6</page-range>.</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mordue</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Monroy</surname> <given-names>F</given-names>
</name>
<name>
<surname>La Regina</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dinarello</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Sibley</surname> <given-names>LD</given-names>
</name>
</person-group>. <article-title>Acute Toxoplasmosis Leads to Lethal Overproduction of Th1 Cytokines</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>167</volume>(<issue>8</issue>):<page-range>4574&#x2013;84</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.167.8.4574</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niedelman</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sprokholt</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Clough</surname> <given-names>B</given-names>
</name>
<name>
<surname>Frickel</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Saeij</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Cell Death of Gamma Interferon-Stimulated Human Fibroblasts Upon <italic>Toxoplasma Gondii</italic> Infection Induces Early Parasite Egress and Limits Parasite Replication</article-title>. <source>Infect Immun</source> (<year>2013</year>) <volume>81</volume>(<issue>12</issue>):<page-range>4341&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00416-13</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rommereim</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Fox</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Butler</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Cantillana</surname> <given-names>V</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Bzik</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>Rhoptry and Dense Granule Secreted Effectors Regulate CD8(<sup>+</sup>) T Cell Recognition of <italic>Toxoplasma Gondii</italic> Infected Host Cells</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>2104</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.02104</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kasper</surname> <given-names>LH</given-names>
</name>
</person-group>. <article-title>Interleukin-10 and Pathogenesis of Murine Ocular Toxoplasmosis</article-title>. <source>Infect Immun</source> (<year>2003</year>) <volume>71</volume>(<issue>12</issue>):<page-range>7159&#x2013;63</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.71.12.7159-7163.2003</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yap</surname> <given-names>G</given-names>
</name>
<name>
<surname>Park</surname> <given-names>D</given-names>
</name>
<name>
<surname>Neyer</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Liesenfeld</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-10 is Required for Prevention of Necrosis in the Small Intestine and Mortality in Both Genetically Resistant BALB/c and Susceptible C57BL/6 Mice Following Peroral Infection With <italic>Toxoplasma Gondii</italic>
</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>164</volume>(<issue>10</issue>):<page-range>5375&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.164.10.5375</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wille</surname> <given-names>U</given-names>
</name>
<name>
<surname>Nishi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lieberman</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Roos</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Hunter</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>IL-10 is Not Required to Prevent Immune Hyperactivity During Memory Responses to <italic>Toxoplasma Gondii</italic>
</article-title>. <source>Parasit Immunol</source> (<year>2004</year>) <volume>26</volume>(<issue>5</issue>):<page-range>229&#x2013;36</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.0141-9838.2004.00704.x</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galv&#xe1;n-Pe&#xf1;a</surname> <given-names>S</given-names>
</name>
<name>
<surname>O'Neill</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>Metabolic Reprograming in Macrophage Polarization</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<elocation-id>420</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2014.00420</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dzik</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Go&#x142;os</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jagielska</surname> <given-names>E</given-names>
</name>
<name>
<surname>Zielinski</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wa&#x142;ajtys-Rode</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>A Non-Classical Type of Alveolar Macrophage Response to <italic>Trichinella Spiralis</italic> Infection</article-title>. <source>Parasit Immunol</source> (<year>2004</year>) <volume>26</volume>(<issue>4</issue>):<fpage>197</fpage>&#x2013;<lpage>205</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.0141-9838.2004.00700.x</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname> <given-names>DR</given-names>
</name>
<name>
<surname>H&#xf6;lscher</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mohrs</surname> <given-names>M</given-names>
</name>
<name>
<surname>Arendse</surname> <given-names>B</given-names>
</name>
<name>
<surname>Schwegmann</surname> <given-names>A</given-names>
</name>
<name>
<surname>Radwanska</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Alternative Macrophage Activation is Essential for Survival During Schistosomiasis and Downmodulates T Helper 1 Responses and Immunopathology</article-title>. <source>Immunity</source> (<year>2004</year>) <volume>20</volume>(<issue>5</issue>):<page-range>623&#x2013;35</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1074-7613(04)00107-4</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roff&#xea;</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rothfuchs</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Santiago</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Marino</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Ribeiro-Gomes</surname> <given-names>FL</given-names>
</name>
<name>
<surname>Eckhaus</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-10 Limits Parasite Burden and Protects Against Fatal Myocarditis in a Mouse Model of <italic>Trypanosoma Cruzi</italic> Infection</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>(<issue>2</issue>):<page-range>649&#x2013;60</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1003845</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Galectin-3 and Galectin-9 May Differently Regulate the Expressions of Microglial M1/M2 Markers and T Helper 1/Th2 Cytokines in the Brains of Genetically Susceptible C57BL/6 and Resistant BALB/c Mice Following Peroral Infection With <italic>Toxoplasma Gondii</italic>
</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1648</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.01648</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>YW</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>RX</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title><italic>Toxoplasma</italic> ROP16(I/III) Ameliorated Inflammatory Bowel Diseases <italic>via</italic> Inducing M2 Phenotype of Macrophages</article-title>. <source>World J Gastroenterol</source> (<year>2019</year>) <volume>25</volume>(<issue>45</issue>):<page-range>6634&#x2013;52</page-range>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v25.i45.6634</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasta</surname> <given-names>GR</given-names>
</name>
</person-group>. <article-title>Galectins as Pattern Recognition Receptors: Structure, Function, and Evolution</article-title>. <source>Adv Exp Med Biol</source> (<year>2012</year>) <volume>946</volume>:<fpage>21</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4614-0106-3_2</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johannes</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jacob</surname> <given-names>R</given-names>
</name>
<name>
<surname>Leffler</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Galectins at a Glance</article-title>. <source>J Cell Sci</source> (<year>2018</year>) <volume>131</volume>(<issue>9</issue>):<fpage>jcs208884</fpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.208884</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Kooyk</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Rabinovich</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>Protein-Glycan Interactions in the Control of Innate and Adaptive Immune Responses</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>(<issue>6</issue>):<fpage>593</fpage>&#x2013;<lpage>601</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni.f.203</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacigalupo</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Manzi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rabinovich</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Troncoso</surname> <given-names>MF</given-names>
</name>
</person-group>. <article-title>Hierarchical and Selective Roles of Galectins in Hepatocarcinogenesis, Liver Fibrosis and Inflammation of Hepatocellular Carcinoma</article-title>. <source>World J Gastroenterol</source> (<year>2013</year>) <volume>19</volume>(<issue>47</issue>):<page-range>8831&#x2013;49</page-range>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v19.i47.8831</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabinovich</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Croci</surname> <given-names>DO</given-names>
</name>
</person-group>. <article-title>Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>36</volume>(<issue>3</issue>):<page-range>322&#x2013;35</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2012.03.004</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellac</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Coimbra</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>F</given-names>
</name>
<name>
<surname>Imboden</surname> <given-names>H</given-names>
</name>
<name>
<surname>Leib</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>Gene and Protein Expression of Galectin-3 and Galectin-9 in Experimental Pneumococcal Meningitis</article-title>. <source>Neurobiol Dis</source> (<year>2007</year>) <volume>28</volume>(<issue>2</issue>):<page-range>175&#x2013;83</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2007.07.005</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Galectins, Eosinophiles, and Macrophages May Contribute to <italic>Schistosoma Japonicum</italic> Egg-Induced Immunopathology in a Mouse Model</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>146</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.00146</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Galectin-Receptor Interactions Regulates Cardiac Pathology Caused by <italic>Trichinella Spiralis</italic> Infection</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>639260</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.639260</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>S</given-names>
</name>
<name>
<surname>He</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Impact of Galectin-Receptor Interactions on Liver Pathology During the Erythrocytic Stage of <italic>Plasmodium Berghei</italic> Malaria</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>758052</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.758052</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Chou</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Yeh</surname> <given-names>LT</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>KI</given-names>
</name>
<etal/>
</person-group>. <article-title>Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases</article-title>. <source>J Immunol</source> (<year>2020</year>) <volume>204</volume>(<issue>5</issue>):<page-range>1158&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1901114</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berrocal Almanza</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Mu&#xf1;oz</surname> <given-names>M</given-names>
</name>
<name>
<surname>K&#xfc;hl</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Kamradt</surname> <given-names>T</given-names>
</name>
<name>
<surname>Heimesaat</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Liesenfeld</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Tim-3 Is Differently Expressed in Genetically Susceptible C57BL/6 and Resistant BALB/c Mice During Oral Infection With <italic>Toxoplasma Gondii</italic>
</article-title>. <source>Eur J Microbiol Immunol (Bp)</source> (<year>2013</year>) <volume>3</volume>(<issue>3</issue>):<page-range>211&#x2013;21</page-range>. doi: <pub-id pub-id-type="doi">10.1556/EuJMI.3.2013.3.10</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gan</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>The Correlation of Tim-3 and IFN-&#x3b3; Expressions in Mice Infected With <italic>Toxoplasma Gondii</italic> During Gestation</article-title>. <source>Parasitol Res</source> (<year>2015</year>) <volume>114</volume>(<issue>1</issue>):<page-range>125&#x2013;32</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00436-014-4167-3</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinay</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>BS</given-names>
</name>
</person-group>. <article-title>4-1bb (CD137), an Inducible Costimulatory Receptor, as a Specific Target for Cancer Therapy</article-title>. <source>BMB Rep</source> (<year>2014</year>) <volume>47</volume>(<issue>3</issue>):<page-range>122&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.5483/BMBRep.2014.47.3.283</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shuford</surname> <given-names>WW</given-names>
</name>
<name>
<surname>Klussman</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tritchler</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Loo</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Chalupny</surname> <given-names>J</given-names>
</name>
<name>
<surname>Siadak</surname> <given-names>AW</given-names>
</name>
<etal/>
</person-group>. <article-title>4-1BB Costimulatory Signals Preferentially Induce CD8<sup>+</sup> T Cell Proliferation and Lead to the Amplification <italic>In Vivo</italic> of Cytotoxic T Cell Responses</article-title>. <source>J Exp Med</source> (<year>1997</year>) <volume>186</volume>(<issue>1</issue>):<fpage>47</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1084/jem.186.1.47</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mittler</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Vella</surname> <given-names>AT</given-names>
</name>
</person-group>. <article-title>Cutting Edge: 4-1BB is a Bona Fide CD8 T Cell Survival Signal</article-title>. <source>J Immunol</source> (<year>1999</year>) <volume>162</volume>(<issue>9</issue>):<page-range>5037&#x2013;40</page-range>.</citation>
</ref>
</ref-list>
</back>
</article>
